United States Pharmacopoeia (USP) Solutions and Reagents
United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.
Found 7624 products of "United States Pharmacopoeia (USP) Solutions and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H29N7O3·C7H8O3SColor and Shape:White Yellow PowderMolecular weight:671.2526Rubber Oligomer 2 (2-(3-chloroprop-1-en-2-yl)-1,1,5,5-tetramethylcyclohexane)
CAS:Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormula:C13H23ClColor and Shape:Pale Yellow LiquidMolecular weight:214.78Rubber Oligomer 6 (2-(3-bromoprop-1-en-2-yl)-1,1,5,5-tetramethylcyclohexane)
CAS:Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormula:C13H23BrColor and Shape:Pale Yellow LiquidMolecular weight:259.23N-Nitroso Atomoxetine Solution (1 mL ) ((R)-N-methyl-N-(3-phenyl-3-(o-tolyloxy)propyl)nitrous amide)
Compounds with other nitrogen function, nesoiFormula:C17H20N2O2Color and Shape:Colorless LiquidMolecular weight:284.15248Eslicarbazepine Acetate Peak ID Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderNeostigmine Related Compound C (3-(Dimethylamino)phenyl dimethylcarbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C11H16N2O2Color and Shape:Light Brown LiquidMolecular weight:208.12118N-Nitroso Benazepril 2-((S)-3-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)(nitroso)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid)
Lactams, nesoiFormula:C24H27N3O6Color and Shape:Off-White Fine PowderMolecular weight:453.18999Eltrombopag Ethyl Ester (ethyl (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate)
CAS:Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structureFormula:C27H26N4O4Color and Shape:Orange SolidMolecular weight:470.19541Parallel Dimer-Octreotide (Bis{D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-L-cysteinamide} cyclic (2-->2'),(7-->7')-bis(disulfide))
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C98H132N20O20S4Color and Shape:Off-White PowderMolecular weight:2036.88096N-Nitroso Biotin Solution (1 mL ) (5-((3aS,4S,6aR)-1-nitroso-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic Acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H15N3O4SColor and Shape:Colorless LiquidMolecular weight:273.07833Methyl Mycophenolate (Methyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate)
CAS:Lactones, nesoiFormula:C18H22O6Color and Shape:White Off-White SolidMolecular weight:334.14164Sorafenib Isopropyl Carbamate (Isopropyl {4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl}carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4Color and Shape:Off-White PowderMolecular weight:329.13756Cross-Reacting Material 197 (CRM197) (Corynebacterium diphtheriae CRM197 Protein)
CAS:Human blood; animal blood prepared for therapeutic, prophylatic or diagnostic uses; antisera and other blood fractions, etc. nesoiColor and Shape:SolidProtocatechuicaldehyde (3,4-Dihydroxybenzaldehyde)
CAS:Aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function, nesoiFormula:C7H6O3Color and Shape:Dark Grey PowderMolecular weight:138.03169Benzil (Diphenylethanedione)
CAS:Aromatic ketones without other oxygen function, nesoiFormula:C14H10O2Color and Shape:Pale Yellow SolidMolecular weight:210.06808Balsalazide Related Compound A ((E)-5-[(p-Carboxyphenyl)azo]-2-salicylic acid, disodium salt)
CAS:Diazo-, azo-, or azoxy-compoundsFormula:C14H8N2Na2O5Color and Shape:Orange PowderMolecular weight:330.022864-(4-Chlorophenyl)-4-Piperidinol (4-(4-Chlorophenyl)piperidin-4-ol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C11H14ClNOColor and Shape:White SolidMolecular weight:211.076392-Benzimidazolinone (1,3-Dihydro-2H-benzimidazol-2-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C7H6N2OColor and Shape:Off-White SolidMolecular weight:134.04801Ammonium Methoxyiminofuranyl Acetate ((Z)-2-(Furan-2-yl)-2-(methoxyimino)acetic acid ammonium salt)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C7H10N2O4Color and Shape:White PowderMolecular weight:186.06406Cidofovir Sodium Uracil Analog ((S)-(((1-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonate, sodium salt)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C8H11N2O7P·2NaColor and Shape:White Off-White SolidMolecular weight:278.03039N-Nitroso Pramipexole ((S)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-propylnitrous amide)
Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormula:C10H16N4OSColor and Shape:SolidMolecular weight:240.10448Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C37H50N6O6Color and Shape:Off-White SolidMolecular weight:674.37918Atazanavir amine analog methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-amino-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C36H50N6O5Color and Shape:Off-White SolidMolecular weight:646.38427Atazanavir S,R,S,S-diastereomer ((3S,8R,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7Color and Shape:White Off-White SolidMolecular weight:704.389755-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H5NO3Color and Shape:White SolidMolecular weight:127.026941,4-Bis(4-(benzothiophen-4-yl)piperazin-1-yl)butane (1,4-bis(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butane)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C28H34N4S2Color and Shape:Off-White SolidMolecular weight:490.22249Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H14N2O2Color and Shape:White Off-White SolidMolecular weight:266.10553Ticlopidine Related Compound A (4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C7H7NOSColor and Shape:White Off-White PowderMolecular weight:153.02484Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C19H23F3N2O5Color and Shape:Off-White SolidMolecular weight:416.15591Nabumetone Alcohol (4-(6'-methoxy-2'-naphthyl)-butan-2-ol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C15H18O2Color and Shape:White PowderMolecular weight:230.13068Doxylamine Alcohol Hydrochloride (1-Phenyl-1-(pyridin-2-yl)ethan-1-ol hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C13H13NO·HClColor and Shape:Off-White SolidMolecular weight:199.09971Sitagliptin (R)-Triazecine Analog ((R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H13F6N5O2Color and Shape:Off-White SolidMolecular weight:421.09734Ambrisentan R-Enantiomer ((R)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C22H22N2O4Color and Shape:White Fine PowderMolecular weight:378.15796Efavirenz Amino Alcohol Ethyl Carbamate (ethyl (S)-(4-chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl)phenyl)carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C16H15ClF3NO3Color and Shape:White SolidMolecular weight:361.06926Monascin
CAS:Lactones, nesoiFormula:C21H26O5Color and Shape:Pale Yellow PowderMolecular weight:358.17802Rosiglitazone Propanamide (3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanamide;3-[4-({2-[Methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]propanamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H21N3O2Color and Shape:Off-White SolidMolecular weight:299.16338Anti-Parallel Dimer-Octreotide Bis{D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-L-cysteinamide} cyclic (2-->7'),(2'-->7)-bis(disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C98H132N20O20S4Color and Shape:Off-White PowderMolecular weight:2036.88096Ambrisentan Related Compound A (4,6-Dimethyl-2-(methylsulfonyl)pyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C7H10N2O2SColor and Shape:Off-White Light Brown Crystalline PowderMolecular weight:186.0463N-Carboxymethyl vinylpyrrolidinone (2-(2-oxo-5-vinylpyrrolidin-1-yl)acetic acid)
CAS:Lactams, nesoiFormula:C8H11NO3Color and Shape:Off-White SolidMolecular weight:169.07389Atenolol Related Compound G (2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}acetic acid)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C14H21NO4Color and Shape:White SolidMolecular weight:267.14706Hydroxypropyl 3-Chlorophenylpiperazine (3-[4-(3-Chlorophenyl) piperazin-1-yl] propan-1-ol)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C13H19ClN2OColor and Shape:Off-White PowderMolecular weight:254.118596α-Hydroxyestradiol ((6S,8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,6,17-triol)
CAS:Phenol-alcoholsFormula:C18H24O3Color and Shape:White Off-White SolidMolecular weight:288.17254Pentazocine Related Compound B ((2R,6R,11R)-3-(3-Hydroxy-3-methylbutyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C19H29NO2Color and Shape:White PowderMolecular weight:303.21983Duloxetine Phthalamide ((S)-2-(methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamoyl)benzoic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C26H23NO4SColor and Shape:White Off-White SolidMolecular weight:445.13478Methyl Dithienyl glycolate (Methyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H10O3S2Color and Shape:White Off-White PowderMolecular weight:254.33 g/molMirabegron N-Thiazolacetyl Analog ((R)-2-(2-aminothiazol-4-yl)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-N-(2-hydroxy-2-phenylethyl)acetamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C26H28N6O3S2Color and Shape:Pale Yellow SolidMolecular weight:536.16643Lamivudine Uracil Derivative (1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidine-2,4(1H,3H)-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C8H10N2O4SColor and Shape:White Off-White PowderMolecular weight:230.03613Ticlopidine Related Compound B (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H12ClNOSColor and Shape:White PowderMolecular weight:277.03281Sulfamerazine
CAS:Sulfonamides used as drugsFormula:C11H12N4O2SColor and Shape:White Light Yellow Pink PowderMolecular weight:264.0681Polyethylene Glycol 1000
CAS:Polyethers, nesoiFormula:HOCH2CH2nOHColor and Shape:White Waxy SolidMolecular weight:950 - 1050
